Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on October 18, 2004

Circulation. 2004
Published online before print October 18, 2004, doi: 10.1161/01.CIR.0000145608.80855.BC
A more recent version of this article appeared on October 26, 2004
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
110/17/2666    most recent
01.CIR.0000145608.80855.BCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massion, P. B.
Right arrow Articles by Balligand, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massion, P. B.
Right arrow Articles by Balligand, J.-L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Contractile function

Submitted on March 15, 2004
Revised on June 10, 2004
Accepted on June 17, 2004

Cardiomyocyte-Restricted Overexpression of Endothelial Nitric Oxide Synthase (NOS3) Attenuates {beta}-Adrenergic Stimulation and Reinforces Vagal Inhibition of Cardiac Contraction

Paul B. Massion MD, Chantal Dessy PhD, Fanny Desjardins MS, Michel Pelat PhD, Xavier Havaux MS, Catharina Belge MD, Pierre Moulin MD, Yves Guiot PhD, Olivier Feron PhD, Stefan Janssens MD, PhD, and Jean-Luc Balligand MD, PhD*

From the Unit of Pharmacology and Therapeutics (P.B.M., C.D., F.D., M.P., C.B., O.F., J.-L.B.), FATH 5349, Unit of Cardiology (X.H.), Department of Medicine, Unit of Anatomopathology (P.M., Y.G.), Université Catholique de Louvain, Brussels, Belgium, and Division of Cardiology (S.J.), Katholieke Universiteit Leuven, Leuven, Belgium.

* To whom correspondence should be addressed. E-mail: balligand{at}mint.ucl.ac.be.

Background--In the heart, nitric oxide synthases (NOS) modulate cardiac contraction in an isoform-specific manner, which is critically dependent on their cellular and subcellular localization. Defective NO production by NOS3 (endothelial NOS [eNOS]) in the failing heart may precipitate cardiac failure, which could be reversed by overexpression of NOS3 in the myocardium.

Methods and Results--We studied the influence of NOS3 in relation to its subcellular localization on the function of cardiomyocytes isolated from transgenic mice overexpressing NOS3 under the {alpha}-myosin heavy chain promoter (NOS3-TG). Immunoblot analysis demonstrated moderate (5-fold) NOS3 overexpression in cardiomyocytes from NOS3-TG heterozygotes. Caveolar localization of transgenic eNOS was demonstrated by immunofluorescence, coimmunoprecipitation with caveolin-3, sucrose gradient fractionation, and immunogold staining revealed by electron microscopy. Compared with wild-type littermate, contractility of NOS3-TG cardiomyocytes analyzed by videomicroscopy revealed a lower incidence of spontaneous arrhythmic contractions (n=32, P<0.001); an attenuation of the {beta}-adrenergic positive inotropic response (isoproterenol, 10-7 mol/L: 62.1±7.8% versus 90.8±8.0% of maximum Ca2+ response; n=10 to 17; P<0.05); a potentiation of the muscarinic negative chronotropic response (carbamylcholine, 3.10-8 mol/L: -63.9±14% versus -27.7±5.6% of basal rate; n=8 to 10; P<0.05), confirmed by telemetry in vivo; and an attenuation of the accentuated antagonism of {beta}-adrenergically stimulated contraction (-14.6±1.5% versus -3.5±1.5; n=7 to 11; P<0.05). Cardiomyocyte NOS inhibition reversed all 4 effects (P<0.05).

Conclusions--Moderate overexpression of NOS3, targeted to caveolae in murine cardiomyocytes, potentiates the postsynaptic muscarinic response and attenuates the effect of high concentrations of catecholamines. Cardiomyocyte NOS3 may represent a promising therapeutic target to restore the sympathovagal balance and protect the heart against arrhythmia.


Key words: contractility • nitric oxide synthase • arrhythmia • acetylcholine • catecholamines




This article has been cited by other articles:


Home page
J. Physiol.Home page
K. E. Brack, V. H. Patel, R. Mantravardi, J. H. Coote, and G. A. Ng
Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation
J. Physiol., June 15, 2009; 587(12): 3045 - 3054.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J.-L. Balligand, O. Feron, and C. Dessy
eNOS Activation by Physical Forces: From Short-Term Regulation of Contraction to Chronic Remodeling of Cardiovascular Tissues
Physiol Rev, April 1, 2009; 89(2): 481 - 534.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Wang, M. J. Kohr, D. G. Wheeler, and M. T. Ziolo
Endothelial nitric oxide synthase decreases {beta}-adrenergic responsiveness via inhibition of the L-type Ca2+ current
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1473 - H1480.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Saliez, C. Bouzin, G. Rath, P. Ghisdal, F. Desjardins, R. Rezzani, L.F. Rodella, J. Vriens, B. Nilius, O. Feron, et al.
Role of Caveolar Compartmentation in Endothelium-Derived Hyperpolarizing Factor-Mediated Relaxation: Ca2+ Signals and Gap Junction Function Are Regulated by Caveolin in Endothelial Cells
Circulation, February 26, 2008; 117(8): 1065 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Moniotte, C. Belge, B. Sekkali, P.B. Massion, B. Rozec, C. Dessy, and J.-L. Balligand
Sepsis is associated with an upregulation of functional {beta}3 adrenoceptors in the myocardium
Eur J Heart Fail, December 1, 2007; 9(12): 1163 - 1171.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Lemmens, K. Doggen, and G. W. De Keulenaer
Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease: Implications for Therapy of Heart Failure
Circulation, August 21, 2007; 116(8): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Seddon, A. M. Shah, and B. Casadei
Cardiomyocytes as effectors of nitric oxide signalling
Cardiovasc Res, July 15, 2007; 75(2): 315 - 326.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Takimoto, D. Belardi, C. G. Tocchetti, S. Vahebi, G. Cormaci, E. A. Ketner, A. L. Moens, H. C. Champion, and D. A. Kass
Compartmentalization of Cardiac {beta}-Adrenergic Inotropy Modulation by Phosphodiesterase Type 5
Circulation, April 24, 2007; 115(16): 2159 - 2167.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Ichinose, E. S. Buys, T. G. Neilan, E. M. Furutani, J. G. Morgan, D. S. Jassal, A. R. Graveline, R. J. Searles, C. C. Lim, M. Kaneki, et al.
Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3 Prevents Myocardial Dysfunction in Murine Models of Septic Shock
Circ. Res., January 5, 2007; 100(1): 130 - 139.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
B. Casadei
The emerging role of neuronal nitric oxide synthase in the regulation of myocardial function
Exp Physiol, November 1, 2006; 91(6): 943 - 955.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. W. Elrod, J. J.M. Greer, N. S. Bryan, W. Langston, J. F. Szot, H. Gebregzlabher, S. Janssens, M. Feelisch, and D. J. Lefer
Cardiomyocyte-Specific Overexpression of NO Synthase-3 Protects Against Myocardial Ischemia-Reperfusion Injury
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1517 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Davidson and M. R. Duchen
Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance
Cardiovasc Res, July 1, 2006; 71(1): 10 - 21.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. R. Martin, K. Emanuel, C. E. Sears, Y.-H. Zhang, and B. Casadei
Are myocardial eNOS and nNOS involved in the {beta}-adrenergic and muscarinic regulation of inotropy? A systematic investigation
Cardiovasc Res, April 1, 2006; 70(1): 97 - 106.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Feron and J.-L. Balligand
Caveolins and the regulation of endothelial nitric oxide synthase in the heart
Cardiovasc Res, March 1, 2006; 69(4): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Godecke
On the impact of NO-globin interactions in the cardiovascular system
Cardiovasc Res, February 1, 2006; 69(2): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-L. Balligand
"La Donna e Mobile...": Is Cardiac Neuronal Nitric Oxide Synthase Such a Disconcerting Enzyme?
Circulation, December 13, 2005; 112(24): 3668 - 3671.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. U. Muller
Increased eNOS expression as a compensatory mechanism reducing {beta}-adrenergic responsiveness?
Cardiovasc Res, September 1, 2005; 67(4): 575 - 577.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E.J.F. Danson, Y.H. Zhang, C.E. Sears, A.R. Edwards, B. Casadei, and D.J. Paterson
Disruption of inhibitory G-proteins mediates a reduction in atrial {beta}-adrenergic signaling by enhancing eNOS expression
Cardiovasc Res, September 1, 2005; 67(4): 613 - 623.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. Wehling-Henricks, M. C. Jordan, K. P. Roos, B. Deng, and J. G. Tidball
Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium
Hum. Mol. Genet., July 15, 2005; 14(14): 1921 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. O-Uchi, K. Komukai, Y. Kusakari, T. Obata, K. Hongo, H. Sasaki, and S. Kurihara
{alpha}1-Adrenoceptor stimulation potentiates L-type Ca2+ current through Ca2+/calmodulin-dependent PK II (CaMKII) activation in rat ventricular myocytes
PNAS, June 28, 2005; 102(26): 9400 - 9405.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. F. Gonzales, F. A. Chung, S. Miranda, L. B. Valdez, T. Zaobornyj, J. Bustamante, and A. Boveris
Heart mitochondrial nitric oxide synthase is upregulated in male rats exposed to high altitude (4,340 m)
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2568 - H2573.
[Abstract] [Full Text] [PDF]